Evidence map›Paper›PMID 42343367›Full record

ArticleBMC health services research2026

Bridging the rural logistics penalty: quantifying structural costs and designing policy mechanisms for home TCM delivery to older adults with chronic respiratory diseases.

Yunanji Zhou, Siyu Xie, Xinyi Qiu, Ting Yuan, Lihua Wang

Abstract read
In one paragraph

Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yunanji Zhou *Qi Huang Chinese Medicine Academy, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330025, China.
Siyu Xie *School of Economics and Management, Central South University of Forestry and Technology, Changsha, Hunan Province, 410004, China.
Xinyi QiuSchool of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330004, China.
Ting YuanSchool of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi Province, 330004, China.
Lihua WangPulmonary Disease Department, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province, 330006, China. 2721322182@qq.com.

Funding

2025 University-level Postgraduate Innovation Special Fund Project XJ-S202554Qihuang Scholar Program No. [2025] 182the Key Laboratory of TCM Pulmonary Science of Jiangxi Province No.2024SSY06321the Key Research and Development Project of Jiangxi Province, the field of Social Development, the development and application of the Yin-Yang Attribute Breath Recognition Instrument for chronic obstructive pulmonary Disease 20232BBG70021
6 · The paper itself

Abstract

backgroundEquitable access to prescribed therapies remains challenging for older adults with chronic respiratory diseases (CRDs) in rural China. Liquid Traditional Chinese Medicine (TCM) decoctions are widely used in respiratory care, but their large volume, thermal sensitivity, and need for temperature-controlled handling make home delivery particularly difficult in geographically dispersed rural settings. The structural and cost implications of this rural cold-chain delivery burden remain insufficiently quantified.

methodsWe developed a four-stage calibrated simulation framework linking CHARLS 2018 microdata with external facility-density statistics, interpretable machine learning, parameterized micro-costing, and policy scenario modelling. The analytic sample included 11,045 adults aged ≥ 60 years, including 2,351 participants with chronic lung disease or asthma. Because CHARLS does not provide patient-level geocoded coordinates or observed residence-to-facility routes, Stage I generated simulation-derived distance distributions rather than observed travel distances, and no patient-level geocoded empirical validation was possible. Stage II used an IADL-based XGBoost-SHAP model to characterize functional vulnerability more directly relevant to medication access and home-delivery prioritization, with ADL retained as a sensitivity outcome. Stage III estimated cold-chain delivery costs under alternative assumptions for consolidation, route tortuosity, and willingness to pay. Stage IV examined cooperation dynamics across subsidy scenarios.

resultsThe calibrated simulation preserved the facility-density-driven rural-urban contrast by design rather than empirically discovering patient routes. Mean modeled distance was 10.61 km for rural residents versus 2.85 km for urban residents, and 10.8% of rural simulated observations exceeded 15 km. The IADL-based XGBoost model achieved an AUC of 0.668 and an accuracy of 0.631; rural residence ranked eighth and was not the leading predictor in the service-vulnerability model. Rural delivery costs exceeded urban benchmarks under all modeled scenarios, with the rural 95th percentile ranging from 34.28 RMB at η = 10 to 77.63 RMB at η = 3. Higher subsidy, willingness to pay, and consolidation efficiency increased cooperation levels, but no scanned condition produced stable three-party cooperation within the 35-55 RMB subsidy range.

conclusionsThis study provides a transparent calibrated-simulation stress test rather than an empirically validated route-reconstruction or subsidy-threshold study. Under the current assumptions, the findings do not support a single transferable subsidy threshold and instead indicate that local pilot calibration, observed route-cost data, and realistic payoff inputs are required before implementation claims can be made.

Indexed as

Health PolicyHealth Services AccessibilityMedicine, Chinese TraditionalAgedAsthmaChinaChronic DiseaseFemaleHumansMaleMiddle AgedRural PopulationCalibrated simulationChronic respiratory diseasesEvolutionary gameHealth equityRural penaltyTCM decoction

Identifiers

PMID42343367
PMCPMC13491821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.